[ad_1]
REUTERS: VBI Vaccines Inc. announced on Monday that an advanced phase-of-stage Hepatitis B vaccine trial had achieved its primary goals.
The trial tested the VBI Sci-B-Vac against GlaxoSmithKline's Engerix-B vaccine, which had been approved for the first time in the United States in 1989.
(Report by Tamara Mathias in Bengaluru, edited by Shailesh Kuber)
Source link
